Insulin enhanced leptin-induced STAT3 signaling by inducing GRP78.
Leptin, an adipocyte-derived hormone, centrally regulates energy homeostasis. Overlaps in the regulation of glucose and energy homeostasis have been reported between leptin and insulin. However, the effects of insulin on leptin's actions in the central nervous system (CNS) have not yet been elucidated in detail. In the present study, we found that insulin potentiated leptin's actions through GRP78 in the neuronal cell line, SH-SY5Y-ObRb. Since insulin induces GRP78, we speculated that it may also enhance leptin's actions through this induction. We found that insulin enhanced leptin-induced STAT3 phosphorylation and this effect was ameliorated by the knockdown of GRP78. The role of GRP78 in leptin's actions was also confirmed by impairments in leptin-induced STAT3 phosphorylation in HEK293-ObRb cells in which GRP78 was knocked down. Furthermore, we found that the overexpression of GRP78 enhanced leptin-induced STAT3 phosphorylation. These results suggest that GRP78 plays an important role in leptin's actions. Furthermore, insulin may enhance the leptin-induced activation of STAT3 by inducing GRP78, which may provide an important connection between insulin and leptin in the CNS.
Department of Pharmacotherapy, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan.
Mina
M
Thon
Department of Pharmacotherapy, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan.
Toru
T
Hosoi
Department of Pharmacotherapy, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan.
Koichiro
K
Ozawa
Curr Opin Cell Biol. 2004 Dec;16(6):653-62
15530777
Cell Metab. 2009 Jan 7;9(1):35-51
19117545
Science. 2000 Sep 22;289(5487):2122-5
11000114
Obes Res. 2005 Jan;13(1):48-57
15761162
Arch Pediatr. 2015 Jan;22(1):111-5
25435272
Methods. 2005 Apr;35(4):373-81
15804610
J Clin Invest. 2011 Jun;121(6):2087-93
21633176
Science. 2004 Oct 15;306(5695):457-61
15486293
FEBS Lett. 2010 Aug 20;584(16):3649-54
20667453
Sci Rep. 2014 Nov 18;4:7096
25403445
Mol Pharmacol. 2008 Dec;74(6):1610-9
18755873
Endocrinology. 2002 Sep;143(9):3498-504
12193563
Cell. 2000 May 26;101(5):451-4
10850487
Cell Metab. 2005 Dec;2(6):411-20
16330326
Diabetes. 2003 Feb;52(2):227-31
12540590
Nat Neurosci. 2005 May;8(5):566-70
15856064
Nature. 1996 Jul 18;382(6588):250-2
8717038
Am J Physiol Endocrinol Metab. 2008 Sep;295(3):E536-44
18492765
Int J Obes (Lond). 2008 Sep;32(9):1431-7
18607383
J Clin Invest. 1967 Oct;46(10):1549-57
6061732
Nat Rev Cancer. 2004 Dec;4(12):966-77
15573118
Diabetes. 2002 Dec;51 Suppl 3:S455-61
12475790
Cell Metab. 2006 Jan;3(1):67-73
16399506
FEBS Lett. 2001 Jul 6;500(3):119-24
11445068
Nat Med. 1996 May;2(5):589-93
8616722
J Biol Chem. 1999 Jan 22;274(4):1865-8
9890935
Nature. 2001 Oct 25;413(6858):794-5
11677594
J Clin Invest. 2001 Oct;108(8):1113-21
11602618
Cell. 2008 Oct 3;135(1):61-73
18854155
J Clin Invest. 1995 Oct;96(4):2065-70
7560100
Mol Cell Biol. 2001 Aug;21(15):5050-62
11438661
Nature. 1979 Nov 29;282(5738):503-5
116135
Eur J Pharmacol. 2006 Dec 28;553(1-3):61-6
17070518
Mol Cell Endocrinol. 2010 Jan 15;314(1):62-9
19698760
FEBS Lett. 2002 Mar 13;514(2-3):122-8
11943137
Mol Endocrinol. 2013 Jun;27(6):990-1003
23579487
Genes Dev. 1999 May 15;13(10):1211-33
10346810
J Cell Physiol. 2012 Dec;227(12):3803-11
22422508
Nature. 1999 Jan 21;397(6716):271-4
9930704
Cell. 2004 Jan 23;116(2):337-50
14744442
Nat Genet. 1996 Sep;14(1):95-7
8782827
Cell Death Differ. 2006 Mar;13(3):385-92
16397584
Mol Cell Biol. 1996 Jun;16(6):2857-64
8649395
J Clin Invest. 2001 May;107(10):1263-73
11375416
Nature. 2000 Apr 6;404(6778):635-43
10766250
Nat Cell Biol. 2000 Jul;2(7):379-84
10878801